Long non-coding RNA CASC2 in human cancer

Slides:

Advertisements

Similar presentations

Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem

Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV Erik De Clercq International Journal of Antimicrobial Agents Volume 33,

The future perspectives in transrectal prostate ultrasound guided biopsy Sung Il Hwang, Hak Jong Lee Prostate International Volume 2, Issue 4, Pages

Treatment of HER2 positive advanced breast cancer with T-DM1: A review of the literature María Teresa Martínez, José Alejandro Pérez-Fidalgo, Paloma Martín-Martorell,

Metastatic melanoma treatment: Combining old and new therapies Ryan J. Davey, Andre van der Westhuizen, Nikola A. Bowden Critical Reviews in Oncology /

Gastrulation Movements: the Logic and the Nuts and Bolts Maria Leptin Developmental Cell Volume 8, Issue 3, Pages (March 2005) DOI: /j.devcel

Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease Yava L. Jones-Hall, Matthew B.

Eribulin—A review of preclinical and clinical studies

Gastric cancer Critical Reviews in Oncology / Hematology

Umesh K. Narta, Shamsher S. Kanwar, Wamik Azmi

Lipid metabolism and lung cancer

Critical Reviews in Oncology / Hematology

Exercise issues in older cancer survivors

Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review Cloé Brami, Ting Bao, Gary Deng Critical.

Novel targets in gastric and esophageal cancer

Critical Reviews in Oncology / Hematology

Nicoletta Colombo, Martin Gore

Invasive lobular breast cancer and its variants: How special are they for systemic therapy decisions? Séverine Guiu, Anita Wolfer, William Jacot, Pierre.

Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force Silvio Monfardini,

Public health value of universal HPV vaccination

Critical Reviews in Oncology / Hematology

Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: A meta-analysis

The case for wider use of recombinant factor VIII concentrates

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical.

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer Sandro Pignata, Enrico.

P53 mutations in triple negative breast cancer upregulate endosomal recycling of epidermal growth factor receptor (EGFR) increasing its oncogenic potency

Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature Omar Abdel-Rahman,

Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: An observational retrospective survey Lazzaro Repetto Critical.

Triplet (FOLFOXIRI) versus doublet (FOLFOX or FOLFIRI) backbone chemotherapy as first-line treatment of metastatic colorectal cancer: A systematic review.

The see-saw of Keap1-Nrf2 pathway in cancer

Amy M. Lin, Charles J. Ryan, Eric J. Small

Mast cells in breast cancer angiogenesis

Genistein: Its role in metabolic diseases and cancer

Jonathan P. Evans, Paul A. Sutton, Boleslaw K. Winiarski, Stephen W

Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti

Rituximab, fludarabine, and cyclophosphamide versus fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia: A systematic review.

Iron overload and chelation therapy in myelodysplastic syndromes

Gene expression arrays in cancer research: methods and applications

A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC) Giorgio Arcangeli,

Abhimanyu Ghose, Ria Kundu, Tahir Latif

Critical Reviews in Oncology / Hematology

Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: From pathology to treatment Judith Maresch, Sebastian F. Schoppmann,

P. Therasse, S. Carbonnelle, J. Bogaerts

TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct.

Critical Reviews in Oncology / Hematology

Olfa Baroudi, Amel Benammar-elgaaied

Clinically useful prognostic factors in acute myeloid leukemia

Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight Giuseppe Aprile, Elena Ongaro, Marzia Del Re, Stefania.

Gwo Yaw Ho, Natasha Woodward, Jermaine I.G. Coward

Critical Reviews in Oncology / Hematology

Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence Ashish Singhal, Muralidharan Jayaraman, Danny.

Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario Alfredo Addeo, Fabrizio Tabbò, Tim Robinson, Lucio Buffoni, Silvia Novello Critical.

Physical activity reduces fatigue in patients with cancer and hematopoietic stem cell transplant recipients: A systematic review and meta-analysis of.

Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders Mai F. Tolba, Hany A.

Gerhard J. Molderings Critical Reviews in Oncology / Hematology

A Mitochondrial Power Play in Lymphoma

Cell signaling and cancer

Regulating Cancer Stem Cells the miR Way

MicroRNAs: Hidden in the Genome

European Urology is “Your” Journal

John D. Gordan, Craig B. Thompson, M. Celeste Simon Cancer Cell

Exercise Controls Non-Coding RNAs

F. van Dijk, H.B. Thio, H.A.M. Neumann EAU-EBU Update Series

RNA Methylation Clears the Way

Jie Huang, Juan Peng, Linlang Guo, MD, PhD

Pitavastatin and HDL: Effects on plasma levels and function(s)

Volume 4, Issue 3, Pages (March 2018)

Long Noncoding RNAs in Cancer Pathways

A Review of First-Line Treatment for Small-cell Lung Cancer

Presentation transcript:

Long non-coding RNA CASC2 in human cancer Giuseppe Palmieri, Panagiotis Paliogiannis, Maria Cristina Sini, Antonella Manca, Grazia Palomba, Valentina Doneddu, Francesco Tanda, Maria Rosa Pascale, Antonio Cossu Critical Reviews in Oncology / Hematology Volume 111, Pages 31-38 (March 2017) DOI: 10.1016/j.critrevonc.2017.01.003 Copyright © 2017 Elsevier B.V. Terms and Conditions

Fig. 1 RNA classes and the mechanisms of lncRNA interaction with pre- e post-trascriptional processes. Critical Reviews in Oncology / Hematology 2017 111, 31-38DOI: (10.1016/j.critrevonc.2017.01.003) Copyright © 2017 Elsevier B.V. Terms and Conditions

Fig. 2 Interactions of CASC2 with miR-18a and proliferation-controlling genes. GFs, growth factors; P, phosphate. Critical Reviews in Oncology / Hematology 2017 111, 31-38DOI: (10.1016/j.critrevonc.2017.01.003) Copyright © 2017 Elsevier B.V. Terms and Conditions

Fig. 3 Interactions of CASC2 with miR-21 and its depending pathways. Black arrows, induction; interrupted red lines, inhibition. Critical Reviews in Oncology / Hematology 2017 111, 31-38DOI: (10.1016/j.critrevonc.2017.01.003) Copyright © 2017 Elsevier B.V. Terms and Conditions